We first confirmed inverse association between RNA levels of HER2 and MLH1 in these tumors at diagnosis (Fig. S7C), indicating that tumors with low MLH1 have relatively higher HER2 at baseline (as observed in our experimental model systems and in TCGA and METABRIC patient tumor datasets). The gene discussed is ERBB2; the disease is neoplasm.